LLNL, UC Davis Partner to Personalize Cancer Medications

News   Oct 29, 2014

 
LLNL, UC Davis Partner to Personalize Cancer Medications
 
 
 

RELATED ARTICLES

Reducing Painkiller Side Effects With Brain Insights

News

Opioids are powerful painkillers that act on the brain, but they have a range of harmful side effects including addiction. Using mass spectrometry, researchers have developed a tool that gives deeper insights into the brain’s response to opioids.

READ MORE

Biorenewable, Biodegradable Plastic Alternative Progress

News

Polymer chemists have taken another step toward a future of high-performance, biorenewable, biodegradable plastics.

READ MORE

Discovery Advances Efforts to Prevent Spread of Cancer

News

Newly identified gene targets could be key to preventing the spread of cancer, new University of Alberta research has shown.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy